Core Viewpoint - Circle's stock (CRCL) experienced a 4% increase following an upgrade to neutral by Mizuho, driven by increased activity on the crypto prediction platform Polymarket, which is expected to boost the demand for Circle's stablecoin, USDC [1] Group 1: Market Activity and Projections - Mizuho's analyst Dan Dolev highlighted that Polymarket's trading volumes for 2026 are projected to reach around $50 billion, which is three times the volume of 2025, indicating a significant growth opportunity for USDC [2] - The current run-rate on Polymarket could potentially increase USDC's market cap by approximately 25% or more [2] - Dolev raised his forecasts for the average USDC in circulation for 2026 and 2027 by approximately 7% and 21% respectively, leading to revenue estimates increases of about 6% and 21% for those years [3] Group 2: Broader Trends and User Base - The rise of event-driven crypto trading is attributed to the diversification of prediction markets into areas such as sports, economics, and pop culture, which has attracted a larger user base [3] - Polymarket is noted for drawing non-crypto-native users into the crypto space through event trading, thereby increasing demand for USDC from outside the traditional DeFi audience [3] Group 3: Competitive Landscape and Price Target - Despite the positive outlook from Polymarket, Dolev refrained from issuing a bullish call, setting a price target of $77, indicating only modest upside from the current price just above $70 [4] - Adverse factors such as potential rate cuts, rising distribution costs, and competition from Tether (USDT) and other financial institutions launching their own stablecoins are seen as offsetting the potential benefits from Polymarket [4] - Circle's stock increase occurred amidst a general decline in crypto-related stocks, coinciding with the stagnant price of bitcoin, which remains below $90,000 [4]

Group 1 - CoreWeave, Inc. announced an expanded collaboration with Nvidia Corporation to build over 5 gigawatts of AI factories by 2030, aiming to enhance global AI adoption [1] - Nvidia invested $2 billion in CoreWeave Class A common stock at a price of $87.20 per share, indicating confidence in CoreWeave's business and growth strategy [2] - CoreWeave plans to utilize Nvidia's accelerated computing platform technology for the AI factories, with Nvidia assisting in the procurement of necessary resources for development [3] Group 2 - Following the announcement, Deutsche Bank analyst upgraded CoreWeave from Hold to Buy, raising the price target from $100 to $140 [4] - Mizuho analyst maintained a Neutral rating on CoreWeave while increasing the price target from $92 to $100 [4]

Mizuho has brought in Jon Connor and Thibaud de Maria as part of a hiring wave of senior investment bankers, said people familiar with the matter who asked not to be identified because it wasn’t public yet https://t.co/8rV2DRQsm5 ...

Group 1 - Chubb Limited (NYSE:CB) is considered one of the best large cap value stocks to buy in 2026, with HSBC upgrading its rating to Buy and setting a price target of $354 [1] - Citizens has increased its price target for Chubb to $350 from $325 while maintaining an Outperform rating, anticipating reduced catastrophe losses and minimal mark-to-market effects in Q4 2025 [2] - Mizuho adjusted its price target for Chubb to $317 from $318 while maintaining a Neutral rating, reflecting a slight reduction after updating models across the insurance group [3] Group 2 - Chubb Limited provides a range of insurance and reinsurance products across six segments: North America Commercial P&C Insurance, North America Personal P&C Insurance, North America Agricultural Insurance, Overseas General Insurance, Global Reinsurance, and Life Insurance [4]

Core Insights - The entry of institutions into the crypto market necessitates heightened caution, particularly regarding compliance and the need for regulated custodians to secure assets [1] - BitGo's public investment listing has generated excitement in both retail and institutional communities, marking it as the first major crypto company to list on a US exchange in 2026 [3][6] - Despite the positive reception of BitGo's IPO, Bitcoin's price remained stable at around $90,000, indicating a cautious market response [4] Company Overview - BitGo is a crypto custodian that manages over $100 billion in assets under custody, providing high-security storage solutions for hedge funds, exchanges, and ETFs [5] - The company raised over $212 million through its IPO by selling 11.8 million Class A shares, with shares debuting at $18, indicating strong demand [7][6] - The IPO was led by major financial institutions including Goldman Sachs and Citigroup, with additional support from Deutsche Bank and Mizuho [8] Market Implications - BitGo's successful IPO serves as a litmus test for other crypto firms, with major players like Grayscale and Kraken closely monitoring its market reception as they consider their own public listings [6] - The strong demand for BitGo shares reflects Wall Street's appetite for crypto infrastructure, even amid a changing regulatory environment [7]

Company Overview - Xcel Energy Inc. is a major utility company in the United States, providing electricity and natural gas services to millions of customers across several states including Colorado, Michigan, Minnesota, New Mexico, North Dakota, South Dakota, Texas, and Wisconsin [1] Analyst Ratings and Price Targets - Morgan Stanley maintains an "Underperform" rating for Xcel Energy, with the stock priced at approximately $76.40, while raising its price target from $79 to $84, indicating a cautious outlook with potential for price appreciation [2] - Weiss Ratings upgraded the stock from a "hold (c+)" to a "buy (b-)" on October 24th, and Mizuho set a price target of $86.00 on January 9th, reflecting a mix of cautious optimism and renewed interest in the company's potential [5] Shareholder Activity - QRG Capital Management Inc. reduced its holdings in Xcel Energy by 20.4%, selling 8,516 shares, while the remaining 33,266 shares are valued at approximately $2.68 million [3] - Twin Peaks Wealth Advisors LLC acquired a new position valued at $25,000, and ORG Partners LLC increased its stake by 168.4% during the third quarter, indicating varied interest from hedge funds [3] Short Interest and Market Sentiment - Xcel Energy's short interest decreased by 22.1% in December to approximately 25.2 million shares, representing about 4.3% of the company's shares being short sold, which indicates a decrease in bearish sentiment among investors [4][6] - The average daily trading volume of 6.8 million shares results in a days-to-cover ratio of 3.7 days, further reflecting the market's sentiment towards the stock [4]

Core Viewpoint - Corvus Pharmaceuticals has initiated an underwritten public offering of $150 million in common stock and pre-funded warrants, with an additional option for underwriters to purchase up to $22.5 million more [1][2]. Group 1: Offering Details - The public offering consists of $150 million in shares of common stock and pre-funded warrants, all offered by Corvus Pharmaceuticals [1]. - The underwriters have a 30-day option to purchase an additional $22.5 million in shares at the public offering price [1]. - The offering is subject to market conditions, and there is no assurance regarding its completion or terms [1]. Group 2: Use of Proceeds - The net proceeds from the offering are expected to be used for working capital and general corporate purposes, including capital expenditures and research and development [2]. - Specific clinical trials funded by the proceeds include Phase 3 for T cell lymphoma and Phase 2 for atopic dermatitis, hidradenitis suppurativa, and asthma [2]. Group 3: Underwriters - Jefferies and Goldman Sachs & Co. LLC are the lead book-running managers for the offering, with Mizuho as the bookrunner and Ladenburg Thalmann as a co-manager [3]. Group 4: Regulatory Information - A shelf registration statement on Form S-3 was declared effective by the SEC on August 15, 2024, allowing the sale of these securities [4]. - A preliminary prospectus supplement will be filed with the SEC on January 20, 2026, and will be available on the SEC's website [4].

Group 1 - Robinhood Markets, Inc. is recognized as a leading cryptocurrency and blockchain stock, with analysts at Piper Sandler maintaining an Overweight rating and a price target of $155 [1] - The company is well-positioned to capitalize on emerging retail trading trends due to its strong brand recognition among US Gen Z and millennial traders, as well as changing investor demographics [2] - Piper Sandler expresses confidence in the management team's ability to identify trends and execute strategies, highlighting the prediction market launched in 2025, which has generated over $300 million in annualized revenue [3] Group 2 - Analysts at Mizuho have also rated Robinhood stock as Outperform with a price target of $172, reflecting confidence in the company's growth prospects in the prediction market segment [4] - Robinhood offers a mobile-first, commission-free platform for trading various financial instruments, aiming to democratize finance with features like fractional shares and crypto wallets [5]

Group 1 - Mastercard Incorporated (NYSE:MA) shares have decreased by 2.8% year-to-date, similar to peers Visa and American Express, following President Trump's suggestion to cap credit card interest rates at 10% [2] - TD Cowen raised Mastercard's price target to $668 from $654 while maintaining a Buy rating, citing consumer spending data and asserting that macroeconomic factors have not impacted the company [2] - Mizuho indicated that while financial technology companies might benefit from the interest rate cap, payment processors like Mastercard could face pressure as banks increase scrutiny of borrowers [2] Group 2 - Jim Cramer expressed agreement with TD Cowen, stating that Mastercard and Visa, as processing companies, would not be affected by the interest rate cap since they do not engage in lending [2] - The article suggests that while Mastercard is a viable investment, there are AI stocks that may offer higher returns with limited downside risk [3]

Group 1 - BrightSpring Health Services Inc. (NASDAQ:BTSG) is considered one of the best young stocks to buy and hold for three years, with Mizuho raising its price target to $45 from $42 while maintaining an Outperform rating [1] - Wells Fargo increased its price target for BrightSpring Health to $43 from $39, maintaining an Overweight rating, and expressed high confidence in Medicare Advantage among managed care organizations [2] - Mizuho's analysis indicates a sequential slowdown in healthcare utilization growth, suggesting that the peak in healthcare demand may have passed [1][3] Group 2 - BrightSpring Health operates as a home and community-based healthcare services platform in the US, divided into two segments: Pharmacy Solutions and Provider Services [4] - Wells Fargo anticipates a more challenging environment for hospitals in 2026 as post-pandemic growth trends fade and legislative risks increase [3]